Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation. 1994;89:2582–9. https://doi.org/10.1161/01.CIR.89.6.2582.
Article
PubMed
CAS
Google Scholar
Cooper LT. Myocarditis. N Engl J Med. 2009;360:1526–38.
Article
PubMed
PubMed Central
CAS
Google Scholar
Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(2636–48):2648a–2648d. https://doi.org/10.1093/eurheartj/eht210.
Article
Google Scholar
Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation. 2005;111:887–93. https://doi.org/10.1161/01.CIR.0000155616.07901.35.
Article
PubMed
Google Scholar
Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005;112:1965–70. https://doi.org/10.1161/CIRCULATIONAHA.105.548156.
Article
PubMed
Google Scholar
McManus BM, Yanagawa B, Rezai N, Luo H, Taylor L, Zhang M, et al. Genetic determinants of coxsackievirus B3 pathogenesis. Ann N Y Acad Sci. 2002;975:169–79. https://doi.org/10.1111/j.1749-6632.2002.tb05950.x.
Article
PubMed
CAS
Google Scholar
Maisch B, Pankuweit S. Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev. 2013;18:761–95.
Article
PubMed
CAS
Google Scholar
Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003;107:2793–8. https://doi.org/10.1161/01.CIR.0000072766.67150.51.
Article
PubMed
CAS
Google Scholar
Kühl U, Lassner D, von Schlippenbach J, Poller W, Schultheiss H-P. Interferon-beta improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol. 2012;60:1295–6. https://doi.org/10.1016/j.jacc.2012.06.026.
Article
PubMed
Google Scholar
Schultheiss H-P, Piper C, Sowade O, Waagstein F, Kapp J-F, Wegscheider K, et al. Betaferon in chronic viral cardiomyopathy (BICC) trial: effects of interferon-β treatment in patients with chronic viral cardiomyopathy. Clin Res Cardiol. 2016;105:763–73. https://doi.org/10.1007/s00392-016-0986-9.
Article
PubMed
CAS
Google Scholar
Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, et al. International Union of Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev. 2014;66:1–79. https://doi.org/10.1124/pr.113.007724.
Article
PubMed
PubMed Central
CAS
Google Scholar
Muntinghe FLH, Verduijn M, Zuurman MW, Grootendorst DC, Carrero JJ, Qureshi AR, et al. CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol. 2009;20:1641–9. https://doi.org/10.1681/ASN.2008040432.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med. 2009;360:692–8. https://doi.org/10.1056/NEJMoa0802905.
Article
PubMed
Google Scholar
Allers K, Hütter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E, et al. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. Blood. 2011;117:2791–9. https://doi.org/10.1182/blood-2010-09-309591.
Article
PubMed
CAS
Google Scholar
Lim JK, Murphy PM. Chemokine control of West Nile virus infection. Exp Cell Res. 2011;317:569–74. https://doi.org/10.1016/j.yexcr.2011.01.009.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hou P, Chen S, Wang S, Yu X, Chen Y, Jiang M, et al. Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection. Sci Rep. 2015;5:15577. https://doi.org/10.1038/srep15577.
Article
PubMed
PubMed Central
CAS
Google Scholar
Afzal AR, Kiechl S, Daryani YP, Weerasinghe A, Zhang Y, Reindl M, et al. Common CCR5-del32 frameshift mutation associated with serum levels of inflammatory markers and cardiovascular disease risk in the Bruneck population. Stroke. 2008;39:1972–8. https://doi.org/10.1161/STROKEAHA.107.504381.
Article
PubMed
CAS
Google Scholar
Lassner D, Siegismund CS, Stehr J, Rohde M, Escher F, Tschöpe C, et al. Recent advances in molecular diagnostics and treatment of heart muscle diseases. J Anal Sci Methods Instrum. 2013;2013(June):98–109.
Google Scholar
Schultheiss H-P, Kühl U, Cooper LT. The management of myocarditis. Eur Heart J. 2011;32:2616–25. https://doi.org/10.1093/eurheartj/ehr165.
Article
PubMed
Google Scholar
Dörner A, Pauschinger M, Schwimmbeck PL, Kühl U, Schultheiss HP. The shift in the myocardial adenine nucleotide translocator isoform expression pattern is associated with an enteroviral infection in the absence of an active T-cell dependent immune response in human inflammatory heart disease. J Am Coll Cardiol. 2000;35:1778–84. https://doi.org/10.1016/S0735-1097(00)00644-6.
Article
PubMed
Google Scholar
Pauschinger M, Phan MD, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, et al. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation. 1999;99:889–95. https://doi.org/10.1161/01.CIR.99.7.889.
Article
PubMed
CAS
Google Scholar
Lassner D, Kühl U, Rohde M, Siegismund CS, Schultheiss H-P. CCR5del32 polymorphism is a protective factor in non-ischemic cardiomyopathy. Int J Cardiol. 2014;173:561–2. https://doi.org/10.1016/j.ijcard.2014.03.123.
Article
PubMed
Google Scholar
Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37:1850–8. https://doi.org/10.1093/eurheartj/ehv727.
Article
PubMed
Google Scholar
Rossol M, Pierer M, Arnold S, Keysser G, Burkhardt H, Baerwald C, et al. Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis. Arthritis Res Ther. 2009;11:R91. https://doi.org/10.1186/ar2733.
Article
PubMed
PubMed Central
CAS
Google Scholar
Galvani AP, Slatkin M. Evaluating plague and smallpox as historical selective pressures for the CCR5-∆32 HIV-resistance allele. Proc Natl Acad Sci USA. 2003;100:15276–9. https://doi.org/10.1073/pnas.2435085100.
Article
PubMed
CAS
Google Scholar
Goel MK, Khanna P, Kishore J. Understanding survival analysis: Kaplan–Meier estimate. Int J Ayurveda Res. 2010;1(4):274–8. https://doi.org/10.4103/0974-7788.76794.
Article
PubMed
PubMed Central
Google Scholar
Bewick V, Cheek L. Ball. Statistics review 12: survival analysis. J Crit Care. 2004;8(5):389–94. https://doi.org/10.1186/cc2955 (Epub 2004 Sep 6).
Article
Google Scholar
Sleijfer S, Bannink M, Gool AR, Kruit WHJ, Stoter G. Side effects of interferon-α therapy. Pharm World Sci. 2005;27:423–31. https://doi.org/10.1007/s11096-005-1319-7.
Article
PubMed
CAS
Google Scholar
Yajima T, Yasukawa H, Jeon E-S, Xiong D, Dorner A, Iwatate M, et al. Innate defense mechanism against virus infection within the cardiac myocyte requiring gp130-STAT3 signaling. Circulation. 2006;114:2364–73. https://doi.org/10.1161/CIRCULATIONAHA.106.642454.
Article
PubMed
CAS
Google Scholar
Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JLF, Varela J, et al. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem. 2010;285:23208–23. https://doi.org/10.1074/jbc.m109.047464.
Article
PubMed
PubMed Central
CAS
Google Scholar
Valaperti A, Nishii M, Liu Y, Naito K, Chan M, Zhang L, et al. Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production. Circulation. 2013;128:1542–54. https://doi.org/10.1161/CIRCULATIONAHA.113.002275.
Article
PubMed
CAS
Google Scholar
Benkirane M, Jin D-Y, Chun RF, Koup RA, Jeang K-T. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5{Delta}32. J Biol Chem. 1997;272:30603–6. https://doi.org/10.1074/jbc.272.49.30603.
Article
PubMed
CAS
Google Scholar
Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol. 2008;28:1950–9. https://doi.org/10.1161/ATVBAHA.107.161224.
Article
PubMed
CAS
Google Scholar
Schober A. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation. 2002;106:1523–9. https://doi.org/10.1161/01.CIR.0000028590.02477.6F.
Article
PubMed
CAS
Google Scholar
Candore G, Balistreri CR, Grimaldi MP, Listì F, Vasto S, Caruso M, et al. Opposite role of pro-inflammatory alleles in acute myocardial infarction and longevity: results of studies performed in a Sicilian population. Ann N Y Acad Sci. 2006;1067:270–5. https://doi.org/10.1196/annals.1354.035.
Article
PubMed
CAS
Google Scholar
Berahovich RD, Miao Z, Wang Y, Premack B, Howard MC, Schall TJ. Proteolytic activation of alternative CCR1 ligands in inflammation. J Immunol. 2005;174:7341–51. https://doi.org/10.4049/jimmunol.174.11.7341.
Article
PubMed
CAS
Google Scholar
Gong X, Gong W, Kuhns DB, Ben-Baruch A, Howard OM, Wang JM. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem. 1997;272:11682–5. https://doi.org/10.1074/jbc.272.18.11682.
Article
PubMed
CAS
Google Scholar
Imai T, The T, Cell-directed CC. Chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997;272:15036–42. https://doi.org/10.1074/jbc.272.23.15036.
Article
PubMed
CAS
Google Scholar
Sirugo G, Predazzi IM, Bartlett J, Tacconelli A, Walther M, Williams SM. G6PD A-deficiency and severe malaria in The Gambia: heterozygote advantage and possible homozygote disadvantage. Am J Trop Med Hyg. 2014;90:856–9. https://doi.org/10.4269/ajtmh.13-0622.
Article
PubMed
PubMed Central
CAS
Google Scholar